|
Market Closed -
Japan Exchange
09:30:00 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 5,690.00 JPY | +0.18% |
|
+0.99% | +4.83% |
Company Valuation: Kobayashi Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 704,427 | 650,295 | 503,841 | 463,131 | 403,511 | 422,987 | - | - |
| Change | - | -7.68% | -22.52% | -8.08% | -12.87% | 4.83% | - | - |
| Enterprise Value (EV) 1 | 596,011 | 546,554 | 424,992 | 398,232 | 333,575 | 360,974 | 353,188 | 347,316 |
| Change | - | -8.3% | -22.24% | -6.3% | -16.24% | 8.21% | -2.16% | -1.66% |
| P/E | 35.8x | 34.8x | 25.3x | 46x | 110x | 41.9x | 31.2x | 25.2x |
| PBR | 3.59x | 3.47x | 2.47x | 2.18x | 1.92x | 2.01x | 1.96x | 1.89x |
| PEG | - | 12.08x | 7.7x | -0.9x | -1.7x | 0x | 0.9x | 1.1x |
| Capitalization / Revenue | 4.54x | 3.91x | 2.9x | 2.8x | 2.43x | 2.45x | 2.35x | 2.27x |
| EV / Revenue | 3.84x | 3.29x | 2.45x | 2.4x | 2.01x | 2.09x | 1.97x | 1.86x |
| EV / EBITDA | 19.3x | 17.1x | 13.3x | 12.1x | 14.1x | 16.4x | 13.1x | 11.1x |
| EV / EBIT | 22.9x | 20.5x | 16.5x | 16x | 22.4x | 27.7x | 20.2x | 16.2x |
| EV / FCF | 31.8x | 31.1x | -350x | -29.2x | 68.5x | 24.8x | 23.1x | 20.2x |
| FCF Yield | 3.15% | 3.22% | -0.29% | -3.42% | 1.46% | 4.03% | 4.33% | 4.96% |
| Dividend per Share 2 | 83 | 90 | 101 | 102 | 104 | 106 | 109.5 | 114.3 |
| Rate of return | 0.92% | 1% | 1.49% | 1.64% | 1.92% | 1.86% | 1.92% | 2.01% |
| EPS 2 | 252.4 | 259.6 | 268.2 | 135.4 | 49.19 | 135.8 | 182.4 | 225.4 |
| Distribution rate | 32.9% | 34.7% | 37.7% | 75.3% | 211% | 78.1% | 60% | 50.7% |
| Net sales 1 | 155,252 | 166,258 | 173,455 | 165,600 | 165,742 | 172,322 | 179,620 | 186,639 |
| EBITDA 1 | 30,900 | 32,027 | 31,837 | 32,800 | 23,600 | 21,965 | 26,990 | 31,262 |
| EBIT 1 | 26,065 | 26,669 | 25,780 | 24,860 | 14,923 | 13,012 | 17,481 | 21,464 |
| Net income 1 | 19,715 | 20,022 | 20,338 | 10,067 | 3,656 | 10,155 | 13,660 | 16,493 |
| Net Debt 1 | -108,416 | -103,741 | -78,849 | -64,899 | -69,936 | -62,013 | -69,799 | -75,671 |
| Reference price 2 | 9,040.00 | 9,030.00 | 6,790.00 | 6,230.00 | 5,428.00 | 5,690.00 | 5,690.00 | 5,690.00 |
| Nbr of stocks (in thousands) | 77,923 | 72,015 | 74,203 | 74,339 | 74,339 | 74,339 | - | - |
| Announcement Date | 2/4/22 A | 2/14/23 A | 2/9/24 A | 2/10/25 A | 2/10/26 A | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 41.91x | 2.09x | 16.43x | 1.86% | 2.64B | ||
| 20.94x | 4.04x | 14.73x | 3.06% | 334B | ||
| 18.62x | 2.79x | 12.3x | 3.43% | 139B | ||
| 24.68x | 3.69x | 15.52x | 2.34% | 72.34B | ||
| 41.7x | 6.72x | 29.15x | 2.21% | 49.42B | ||
| 34.87x | 2.65x | 14.51x | 1.56% | 37.41B | ||
| 20.16x | 2.82x | 11.74x | 4.4% | 36.82B | ||
| 23.64x | 1.73x | 11.04x | 2.15% | 20.56B | ||
| 21.2x | 1.38x | 8.96x | 1.24% | 20.35B | ||
| 16.22x | 1.55x | 8.89x | 3.27% | 19.81B | ||
| Average | 26.39x | 2.95x | 14.33x | 2.55% | 73.28B | |
| Weighted average by Cap. | 22.97x | 3.60x | 14.74x | 2.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 4967 Stock
- Valuation Kobayashi Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















